Cannabis and Cannabinoids

On Nov 17, 2020

In this multi-part series, I’ll examine some of the research around cannabis and cannabinoids. All research is current and cited below.

Citations:
1. Marijuana: Current Concepts
Front Public Health. 2013; 1: 42.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859982/

2. Cannabinoid Receptors: Nomenclature and Pharmacological Principles
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jul 2; 38(1): 4–15.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378782/

3. Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Curr Med Chem. 2010; 17(14): 1468–1486.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120766/

4. Modulation of l-α-Lysophosphatidylinositol/GPR55 Mitogen-activated Protein Kinase (MAPK) Signaling by Cannabinoids
J Biol Chem. 2012 Jan 2; 287(1): 91–104.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249141/

5. Vascular targets for cannabinoids: animal and human studies
Br J Pharmacol. 2014 Mar; 171(6): 1361–1378.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954478/

6. Cannabis and endocannabinoid modulators: Therapeutic promises and challenges
Clin Neurosci Res. 2005; 5(2-4): 185–199.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2544377/

7. Prospective Associations between Cannabis Use, Abuse, and Dependence and Panic Attacks and Disorder
J Psychiatr Res. 2008 Oct; 42(12): 1017–1023.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600535/

8. Schizophr Res Treatment. 2011; 2011: 501726.
Cannabinoids for the Treatment of Schizophrenia? A Balanced Neurochemical Framework for Both Adverse and Therapeutic Effects of Cannabis Use
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428612/

9. Negative consequences associated with dependence in daily cannabis users
Subst Abuse Treat Prev Policy. 2007; 2: 3.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1783648/

10. How high: Quantity as a predictor of cannabis-related problems
Harm Reduct J. 2008; 5: 20.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2438353/

source